BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 12901778)

  • 21. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery].
    Larumbe R
    Rev Med Univ Navarra; 1997; 41(1):6-11. PubMed ID: 9527716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease.
    Knox MR; Lacritz LH; Chandler MJ; Munro Cullum C
    Clin Neuropsychol; 2003 May; 17(2):216-9. PubMed ID: 13680428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):113-22. PubMed ID: 12050474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visuospatial dysfunction may be a key in the differentiation between Alzheimer's disease and subcortical cognitive impairment in moderate to severe stages.
    Fukui T; Lee E; Kitamura M; Hosoda H; Bokui C; Ikusu K; Okita K
    Dement Geriatr Cogn Disord; 2009; 28(4):288-94. PubMed ID: 19828949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in cognitive presentation of Alzheimer's disease.
    Stopford CL; Snowden JS; Thompson JC; Neary D
    Cortex; 2008 Feb; 44(2):185-95. PubMed ID: 18387548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences exist in the cognitive profile of mild Alzheimer's disease and subcortical ischemic vascular dementia.
    Kandiah N; Narasimhalu K; Lee J; Chen CL
    Dement Geriatr Cogn Disord; 2009; 27(5):399-403. PubMed ID: 19339778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related cognitive decline in patients with mood disorders.
    Gualtieri CT; Johnson LG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):962-7. PubMed ID: 18243461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia].
    Juhász LZ; Kemény K; Linka E; Sántha J; Bartkó G
    Ideggyogy Sz; 2003 Sep; 56(9-10):303-8. PubMed ID: 14608951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination.
    Kuslansky G; Katz M; Verghese J; Hall CB; Lapuerta P; LaRuffa G; Lipton RB
    Arch Clin Neuropsychol; 2004 Jan; 19(1):89-104. PubMed ID: 14670382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological markers of dementia in patients with memory complaints.
    Guarch J; Marcos T; Salamero M; Blesa R
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):352-8. PubMed ID: 15065228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease.
    Tsiskaridze A; Shakarishvili R; Janelidze M; Vashadze T; Chikhladze M
    Funct Neurol; 1998; 13(1):17-25. PubMed ID: 9584871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.